Role of Cardiac Scintigraphy With 99mTc-DPD in the Differentiation of Cardiac Amyloidosis Subtype
详细信息    查看全文
文摘

Introduction and objectives

We investigated the diagnostic accuracy of technetium-99m-3,3-diphosphono-1,2 propanodicarboxylic acid (99mTc-DPD) scintigraphy in differentiating between monoclonal immunoglobulin light chain and transthyretin-related cardiac amyloidosis.

Methods

Nineteen patients with documented cardiac amyloidosis were included: 8 with transthyretin-related amyloidosis (group A) and 11 with light chain amyloidosis (group B). All the patients underwent scintigraphy with 99mTc-DPD and technetium-99m-methylene diphosphonate (99mTc-MDP).

Results

On visual scoring, cardiac 99mTc-DPD uptake could be characterized as moderate to severe (scores of 2-3), with ventricular or biventricular distribution, in all group A patients (transthyretin-related cardiac amyloidosis), and was absent or mild (scores of 0-1) and diffusely distributed in all group B patients (monoclonal immunoglobulin light chain cardiac amyloidosis). 99mTc-DPD uptake was also absent (score of 0) among unaffected controls and in 2 unaffected relatives of patients with hereditary transthyretin-related amyloidosis who harbor a mutation in the transthyretin gene. With 99mTc-MDP, all the patients had a myocardial uptake score of 0-1. In our series, selective myocardial uptake of 99mTc-DPD provided 100 % accuracy (95 % CI, 97.37 % -100 % ) for the differentiation between transthyretin-related and light chain cardiac amyloidosis.

Conclusions

We conclude that 99mTc-DPD scintigraphy is a useful test for the differential diagnosis of transthyretin versus light chain etiology in patients with cardiac amyloidosis.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700